DK402877A - 1-amino-2-hydroxy-3-heterocyclyloxy-propansalte deraf samt fremgangsmaade til fremstilling deraf - Google Patents

1-amino-2-hydroxy-3-heterocyclyloxy-propansalte deraf samt fremgangsmaade til fremstilling deraf

Info

Publication number
DK402877A
DK402877A DK402877A DK402877A DK402877A DK 402877 A DK402877 A DK 402877A DK 402877 A DK402877 A DK 402877A DK 402877 A DK402877 A DK 402877A DK 402877 A DK402877 A DK 402877A
Authority
DK
Denmark
Prior art keywords
propansals
heterocyclyloxy
hydroxy
procedures
amino
Prior art date
Application number
DK402877A
Other languages
Danish (da)
English (en)
Inventor
F Ostermayer
H Schroeter
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK402877A publication Critical patent/DK402877A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK402877A 1976-10-05 1977-09-09 1-amino-2-hydroxy-3-heterocyclyloxy-propansalte deraf samt fremgangsmaade til fremstilling deraf DK402877A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1263576A CH607585A5 (en) 1976-10-05 1976-10-05 Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine

Publications (1)

Publication Number Publication Date
DK402877A true DK402877A (da) 1978-04-06

Family

ID=4384944

Family Applications (1)

Application Number Title Priority Date Filing Date
DK402877A DK402877A (da) 1976-10-05 1977-09-09 1-amino-2-hydroxy-3-heterocyclyloxy-propansalte deraf samt fremgangsmaade til fremstilling deraf

Country Status (21)

Country Link
JP (1) JPS5350177A (ja)
AT (1) AT358037B (ja)
AU (1) AU514676B2 (ja)
BE (1) BE858867A (ja)
CA (1) CA1105021A (ja)
CH (1) CH607585A5 (ja)
DE (1) DE2740678A1 (ja)
DK (1) DK402877A (ja)
ES (1) ES462389A1 (ja)
FI (1) FI772681A (ja)
FR (1) FR2367065A1 (ja)
GB (1) GB1591723A (ja)
GR (1) GR71677B (ja)
IE (1) IE45692B1 (ja)
IL (1) IL53013A (ja)
NL (1) NL7710394A (ja)
NO (1) NO773125L (ja)
NZ (1) NZ185267A (ja)
PT (1) PT67048B (ja)
SE (1) SE7710250L (ja)
ZA (1) ZA775698B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208416A (en) * 1978-06-27 1980-06-17 Merck & Co., Inc. N-Aralkyl containing cyanopyridines
DK267779A (da) * 1978-06-27 1979-12-28 Merck & Co Inc Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes
DE3776011D1 (de) * 1986-06-30 1992-02-27 Toyo Jozo Kk 2-substituierte alkoxy-3-substituierte pyrazine.
WO2001036412A1 (en) * 1999-11-15 2001-05-25 Eli Lilly And Company Process for the preparation of aryloxy propanolamines

Also Published As

Publication number Publication date
BE858867A (fr) 1978-03-20
GR71677B (ja) 1983-06-21
AU2912577A (en) 1979-04-05
ATA648777A (de) 1980-01-15
FR2367065A1 (fr) 1978-05-05
ES462389A1 (es) 1978-07-01
FR2367065B1 (ja) 1980-10-10
NZ185267A (en) 1979-07-11
IE45692L (en) 1978-04-05
PT67048B (de) 1979-02-16
NO773125L (no) 1978-04-06
CA1105021A (en) 1981-07-14
CH607585A5 (en) 1978-09-15
DE2740678A1 (de) 1978-04-06
NL7710394A (nl) 1978-04-07
IE45692B1 (en) 1982-10-20
IL53013A (en) 1981-09-13
ZA775698B (en) 1978-05-30
SE7710250L (sv) 1978-04-06
FI772681A (fi) 1978-04-06
AT358037B (de) 1980-08-11
GB1591723A (en) 1981-06-24
JPS5350177A (en) 1978-05-08
AU514676B2 (en) 1981-02-19
IL53013A0 (en) 1977-11-30
PT67048A (de) 1977-10-01

Similar Documents

Publication Publication Date Title
DK313977A (da) Kateter samt fremgangsmade til fremstilling deraf
DK119577A (da) Peptid samt fremgangsmade til fremstilling deraf
DK357677A (da) Bererfikserede enzymer samt fremgangsmade til fremstilling og anvendelse heraf
DK397777A (da) Thiazolindinderivater samt fremgangsmaade til fremstilling deraf
RO81244A (ro) Procedeu pentru obtinerea dimetileterului
DK21079A (da) Substituerede heterocycloske benzamider samt fremgangsmaade til fremstilling deraf
DK25177A (da) 1,2-benzisothiazolinoner-3 samt fremgangsmade til fremstilling deraf
DK545077A (da) Thiooximcephalosporin- og penicillinderivater samt fremgangsmaader til fremstilling deraf
DK49077A (da) Piperazinderivater samt fremgangsmade til fremstilling deraf
DK388377A (da) Cephalosporiner samt fremgangsmaade til fremstilling deraf
SE7704322L (sv) Tiokarbamidderivat samt forfarande for framstellning derav
SE426691B (sv) Lera-cementbruk samt forfarande for framstellning av detsamma
DK303178A (da) Benzylpyrimidiner samt fremgangsmaade til fremstilling deraf
FI53275C (fi) Falsfog foer plastfolier samt hopfogningsapparat
DK402877A (da) 1-amino-2-hydroxy-3-heterocyclyloxy-propansalte deraf samt fremgangsmaade til fremstilling deraf
FI772989A (fi) Dialysapparat samt foerfarande foer framstaellning av densamma
DK301877A (da) Varmeelement samt fremgangsmade til fremstilling heraf
NO150366C (no) Traadtau samt framgangsmaate for framstilling av dette
DK569077A (da) Fremgangsmaade til fordeling af tofligede kapsler samt kapsel til udoevelse af fremgangsmaaden
DK170779A (da) Phenoxyalkyltrialkoxysilaner samt fremgangsmaade til fremstilling heraf
DK159160C (da) Nitroaryl-malto-n-osider samt fremgangsmaade til fremstilling deraf
DK313576A (da) 1-methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoler samt fremgangsmade til fremstilling deraf
SE7611478L (sv) Sintringsforfarande samt anleggning for utforande av forfarandet
DK59277A (da) Naphthalenonphthalazinylhydrazoner samt fremgangsmade til fremstilling deraf
DK571277A (da) Haegte til linninger og lignende